Landscapes / Targets
FAP
18 drugs act on FAP, in 20 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs18
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Aug 2027Phase 3 trial completes | |||
| Next date | 30 Aug 2027 · Phase 3 trial completes | ||||
| Also tested for | Esophageal Cancer, Gastric Cancer (GC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Malignant Pleural Mesotheliomas | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 2 | 7 Jul 2027Phase 2 trial completes | ||
| Next date | 7 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Liver Fibrosis, Hepatic Cirrhosis | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | ||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Jan 2028Phase 1/2 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer, Epithelial Ovarian Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Jan 2028Phase 1/2 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Pancreatic Ductal Adenocarcinoma, Gastric Cancer and 6 more | ||||
| Open drug page | |||||
— |
Phase 2 | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Colorectal Cancer, Epithelial Ovarian Cancer and 3 more | ||||
| Open drug page | |||||
64Cu-LNTH-1363Snot checked |
— |
Phase 1/2 | — | ||
| Also tested for | Metastatic Sarcoma, Esophageal Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | Oct 2027Phase 1 trial completes | |||
| Next date | Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor Malignancy | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Pancreatic Adenocarcinoma Metastatic | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2028Phase 1 trial completes | |||
| Next date | Jan 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Soft Tissue Sarcoma | ||||
| Open drug page | |||||
— |
Phase 1 | 31 May 2028Phase 1 trial completes | |||
| Next date | 31 May 2028 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 1 | Jul 2028Phase 1 trial completes | ||
| Next date | Jul 2028 · Phase 1 trial completes | ||||
| Also tested for | Ovarian Neoplasms, Breast Neoplasms and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2029Phase 1 trial completes | |||
| Next date | Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Solid Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Salivary Gland Tumor, Urothelial Carcinoma and 3 more | ||||
| Open drug page | |||||
— |
Boehringer Ingelheim · Private |
Phase 1 | — | ||
| Also tested for | Neoplasms | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 17 of 18 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026